Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...

Johnson & Johnson said its combination therapy for lung cancer outperformed AstraZeneca Plc’s blockbuster Tagrisso in a ...

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Medicare Advantage insurance may lead to lower use of high-cost cancer drugs, particularly for colorectal cancer A new study ...

Moreover, secreted factors from primary tumours alter immune cells and the extracellular matrix of the lung, creating a ...